September 17, 2014 10:27 AM ET

Pharmaceuticals

Company Overview of QR Pharma, Inc.

Company Overview

QR Pharma, Inc. develops drugs for the treatment of mild cognitive impairment, Alzheimer's, Parkinson's, and Down Syndrome diseases. It offers Posiphen compound for mild cognitive impairment and early stage Alzheimer's disease; and Bisnorcymserine compound that inhibits amyloid formation and prevents the progression of the Alzheimer's disease. QR Pharma, Inc. was founded in 2008 and is based in Radnor, Pennsylvania.

259 Radnor Chester Road

Suite 205

Radnor, PA 19087

United States

Founded in 2008

Phone:

484-253-2296

Fax:

484-253-2288

Key Executives for QR Pharma, Inc.

Vice President of Operations
Vice President of Formulation
Strategic Advisor and Director
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Biosynexus Incorporated United States
Aponia Laboratories Inc. United States
Velius, LLC United States
CardioPharma, Inc. United States
Acretia, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QR Pharma, Inc., please visit www.qrpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.